Clinical significance of pathologic subtype in curatively resected ampulla of vater cancer
Authors:
- 31 August 2011
- journal article
- research article
- Published by Wiley in Journal of Surgical Oncology
- Vol. 105 (3) , 266-272
Abstract
Background: Ampullary cancer is considered to have a better prognosis than cancers of the distal bile duct and pancreas, and recent publications emphasize the prognostic importance of the histologic differentiation of the intestinal and pancreatobiliary types of ampullary cancer. The aims of this study were to identify those factors that affect recurrence after curative resection and to investigate differences between the clinicopathologic features of these two pathologic subtypes.Patients and Methods: The medical records of patients that underwent pancreatoduodenectomy for ampullary carcinoma from February 1995 to March 2009 at our institute were retrospectively reviewed. One hundred and four patients that underwent curative resection for ampullary carcinoma were enrolled in this study. One pathologist reviewed all pathologic reports and histopathologic findings. Data on clinicopathologic factors and disease free and overall survival were analyzed.Results: The 3‐ and 5‐year disease free survival rates of the 104 study subjects were 62.2% and 57.7%, respectively, and overall survival rates were 69.4% and 60.1%, respectively. Multivariate analysis showed that an advanced T stage (P = 0.049), the presence of lymph node metastasis (P = 0.003), poor differentiation (P = 0.039), and the pancreatobiliary type (P = 0.022) significantly increased the risk of recurrence. Furthermore, the pancreatobiliary type was found to be more associated with an advanced T stage (P = 0.009), regional lymph node metastasis (P = 0.007), and perineural invasion (P = 0.026) than the intestinal type. In addition, pathologic subtype analysis showed that Carcinoembryonic antigen (CEA) level and lymph node metastasis were important predictors of recurrence in patients with the intestinal (P = 0.013) and pancreatobiliary types, respectively (P = 0.003).Conclusions: An advanced T stage, nodal metastasis, poor differentiation, and the pancreaticobiliary type were found to be independent predictors of recurrence after curative resection of ampullary carcinoma by multivariate analysis. In addition, the pancreatobiliary type tended to present in a more advanced T stage and more frequently with regional lymph node involvement and perineural invasion than the intestinal type. Furthermore, CEA level and lymph node metastasis were found to be independent predictors of recurrence for the intestinal and pancreatobiliary types, respectively. J. Surg. Oncol. 2012; 105:266–272.Keywords
This publication has 24 references indexed in Scilit:
- Lymph Node Involvement and Not the Histophatologic Subtype Is Correlated with Outcome After Resection of Adenocarcinoma of the Ampulla of VaterJournal of Gastrointestinal Surgery, 2010
- Tumors of the Ampulla of Vater: Histopathologic Classification and Predictors of SurvivalJournal of the American College of Surgeons, 2008
- Tumor-related factors and patient’s age influence survival after resection for ampullary adenocarcinomaJournal of Hepato-Biliary-Pancreatic Surgery, 2008
- Pancreatobiliary versus intestinal histologic type of differentiation is an independent prognostic factor in resected periampullary adenocarcinomaBMC Cancer, 2008
- Neoplastic diseases of the papilla of VaterJournal of Hepato-Biliary-Pancreatic Surgery, 2004
- Neoplasms of the Ampulla of Vater with Concurrent Pancreatic Intraductal Neoplasia: A Histological and Molecular StudyLaboratory Investigation, 2001
- Adenoma—Carcinoma Sequence in the Papilla of VaterScandinavian Journal of Gastroenterology, 1996
- Different Clinicopathologic Findings in Two Histologic Types of Carcinoma of Papilla of VaterJapanese Journal of Cancer Research, 1994
- Adenoma of the ampulla of Vater: putative precancerous lesion.Gut, 1991
- Long-term survival after resection of ampullary carcinoma is associated independently with tumor grade and a new staging classification that assesses local invasivenessCancer, 1988